Back to Search
Start Over
Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I
- Source :
- Molecular Genetics and Metabolism. 123:S54
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
- Subjects :
- business.industry
Endocrinology, Diabetes and Metabolism
05 social sciences
020206 networking & telecommunications
02 engineering and technology
Pharmacology
Biochemistry
Fusion protein
Receptor antibody
Mucopolysaccharidosis type I
Endocrinology
0202 electrical engineering, electronic engineering, information engineering
Genetics
Human insulin
Medicine
0501 psychology and cognitive sciences
Clinical efficacy
business
Iduronidase
Molecular Biology
050104 developmental & child psychology
Subjects
Details
- ISSN :
- 10967192
- Volume :
- 123
- Database :
- OpenAIRE
- Journal :
- Molecular Genetics and Metabolism
- Accession number :
- edsair.doi...........e6f6339da84676faa456a4610e049891
- Full Text :
- https://doi.org/10.1016/j.ymgme.2017.12.128